BOME MINERAL HOMEOSTASIS Flashcards
hormone replacement
estrogen + progestin
estrogen + progestin MOA
estrogen: decrease RANKL/IL-6
progestin: reduce risk for endometrial cancer
side effects of hormone replacement
breast cancer
venous thrombosis
SERM
raloxifene
SERM MOA
ER agonist at bone
ER antagonist at endometrium and breast
which drug to treat osteoporosis + prevent breast cancer
SERM
analogues of pyrophosphate that decrease osteoclast activity
bisphosphonates
name the important BISPHOSPHONATES
-DRONATE
alendronate
pamidronate
zoledronate
which bisphosphonates are IV
pamidronate and zoledronate
purpose of bisphosphonates**
osteoporosis
paget disease
osteolytic bone lesions of multiple myeloma+breast
hypercalcemia associated w maligancy
big side effect of bisphosphonates
jaw osteonecrosis in cancer patients
when do bisphosphonates need to be taken
empty stomach
denosumab
RANKL antagonist - decrease osteoclast activity
when is denosumab given
monthly-malignancy
6 months- osteoporosis
both subQ
main tx for hypercalcemia
nasal spray salmon calcitonin
side effect of salmon calcitonin
tachyphylaxis a few days later
-flushing, nausea, diarrhea
PTH analogue
teriparatide
- pulsatile NOT CONTINUOUS
- stimulates osteoblasts
hPTH 1-34 purpose
severe osteoporosis
teriparatide given with what to reduce side effects
aledronate
oral phosphate binder
calcium carbonate
calcium acetate
aluminum hydroxide
sevelamer
purpose of oral phosphate binders
chronic kidney disease
tumoral calcinosis
hyperPTH-hypertosis sydrome
which oral phosphate binder needs acidic gastric pH for activation
CaCO3 absorption
which oral phosphate binder lowers serum cholesterol
sevelamer
MOA - cinacalcet
increases sensitivity of calcium sensing PTH cells, causing decrease PTH secretion